Chemours Commends the European Patent Office for Upholding Solstice’s HFO-1234yf Process Patent

The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company, applauds the decision by the Boards of Appeal of the European Patent Office to uphold European Patent EP 2546225, which protects HFO-1234yf manufacturing processes.

This ruling represents an important victory, ensuring both intellectual property (IP) protection of low global warming potential (GWP) refrigerants while helping to ensure the market has access to safe, reliable, and high-quality refrigerants that advance global climate targets.

Chemours and Solstice have made significant long-term investments to bring 1234yf to market, and we remain firmly committed to defending our IP- extending into the mid-2030s-and market position as authorized manufacturers and suppliers.

Chemours operates one of the world's largest HFO-1234yf production facilities, and will continue investing to meet rising global demand, while maintaining rigorous standards for manufacturing, distribution, and responsible use-ensuring strong support for customers and continued progress toward climate-friendly solutions.

News Media Inquiries

Please email us at